financetom
Business
financetom
/
Business
/
Vinod Khosla quotes Warren Buffett amid funding winter
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vinod Khosla quotes Warren Buffett amid funding winter
Jul 7, 2023 2:36 AM

Billionaire venture capitalist Vinod Khosla on July 7 acknowledged that the funding environment is down, but all it means is your competition is also not getting funding.

Speaking at Moneycontrol Startup Conclave via video conferencing, Khosla, founder of Khosla Ventures and early investor in OpenAI, exuded confidence, saying the capital efficiency will go up. And with all retrenchments across sectors, it is a perfect time to hire for entrepreneurs.

Ace investor Warren Buffett always says that you should be "fearful when others are greedy …,” Khosla said, explaining the existing funding environment.

“We have to make the best of the really unfortunate events such as Covid-19 as it has created a huge opportunity for India because everyone is trying to not bank on China,” he emphasised.

The billionaire venture capitalist further elaborated that India is best positioned to take advantage of Chinese management of Covid-19. Also, India has so much technical talent to take advantage of that opportunity.

However, national government priorities are different from startups, he pointed out.

India is very aligned with Western values … India can have more global companies and what is happening with China will actually enhances the interest in investing in India, he stated.

Moneycontrol Startup Conclave aims to highlight the resilience and determination of entrepreneurs and their unwavering commitment to overcoming obstacles.

Also Read: M&A trends emerge as startups seek rescue amidst cash crunch

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Guardian Pharmacy Services Launches IPO
Guardian Pharmacy Services Launches IPO
Sep 16, 2024
01:41 PM EDT, 09/16/2024 (MT Newswires) -- Guardian Pharmacy Services said Monday it has launched its underwritten initial public offering of 6.75 million class A common shares. The company said it expects to grant the underwriters a 30-day option to buy up to about 1 million additional shares at the IPO price, less the underwriting discount. The estimated IPO price...
Global wind turbine orders driven higher in H1 2024 on Chinese demand
Global wind turbine orders driven higher in H1 2024 on Chinese demand
Sep 16, 2024
Sept 16 (Reuters) - Global onshore wind turbine orders hit 91.2 gigawatts (GWs) in the first half of the year, a 23% year-on-year rise, due to higher demand in the second quarter from China's northern region, Wood Mackenzie said in a report on Monday. WHY IT'S IMPORTANT China's wind turbine production capacity is by far the biggest globally compared to...
FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers
FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers
Sep 16, 2024
Monday, the FDA lifted the partial clinical hold on studies of Zentalis Pharmaceuticals, Inc.’s azenosertib, the company’s novel, selective, and orally bioavailable inhibitor of WEE1. The FDA has cleared the company to resume enrollment in all ongoing azenosertib clinical studies with no changes in the clinical development plan. Zentalis will be working with clinical trial investigators to resume study activities...
Korro Bio Partners With Novo Nordisk to Develop Genetic Medicines
Korro Bio Partners With Novo Nordisk to Develop Genetic Medicines
Sep 16, 2024
09:09 AM EDT, 09/16/2024 (MT Newswires) -- Korro Bio ( KRRO ) said Monday it has partnered with Novo Nordisk (NVO) to discover and develop new genetic medicines, with an initial focus on cardiometabolic disease treatments. Under terms of the partnership, Korro will receive $530 million in upfront, development and commercial milestone payments, in addition to tiered royalties and research...
Copyright 2023-2026 - www.financetom.com All Rights Reserved